Carregant...
Oral contraceptives and the risk of gallbladder disease: a comparative safety study
BACKGROUND: Recent concerns have been raised about the risk of gallbladder disease associated with the use of drospirenone, a fourth-generation progestin used in oral contraceptives. We conducted a study to determine the magnitude of this risk compared with other formulations of oral contraceptives....
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Canadian Medical Association
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3091897/ https://ncbi.nlm.nih.gov/pubmed/21502354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.110161 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|